Beauty

Shiseido to sell Aupres China unit to IDG-led consortium

The binding agreement covers Shiseido Liyuan Cosmetics, including its Beijing factory, and gives IDG-managed funds 95% of the equity.

Naomi SekiguchiNovember 19, 20265 min read1 views

An unbranded cosmetic bottle and jar stand between translucent panels evoking a business transfer, with factory and city forms in the background.

Shiseido has signed a binding agreement to sell its entire Chinese subsidiary, Shiseido Liyuan Cosmetics (SLC), to an investor consortium led by Hong Kong-based private equity firm IDG Capital. SLC makes and sells the Aupres brand in China. The financial terms were not disclosed. The transaction is expected to close between the fourth quarter of 2026 and the first quarter of 2027, subject to regulatory approvals, including in China.

Shiseido frames the sale as part of its 2030 Medium-Term Strategy to improve profitability and capital efficiency. The company says it wants to focus management resources on areas where it enjoys the greatest competitive advantage, while pursuing sustainable growth and stronger competitiveness in China. Shiseido described China as a strategically important and attractive market whose competitive landscape is evolving with e-commerce expansion, changing consumer behavior and the emergence of diverse market participants. The divestment, it says, will let the group concentrate on priority brands and higher-growth opportunities.

SLC was established in 1991 as a joint venture with Beijing Liyuan, a subsidiary of Yiqing Group owned by the Beijing Municipal Government. It has sold the C-beauty brand Aupres since 1994. The current joint venture agreement is due to expire in December 2026, and the parties agreed not to renew it. On September 1, 2026, Shiseido acquired Beijing Liyuan's 35% stake, giving it full ownership ahead of the sale.

Under the transaction, funds managed by IDG Capital will take 95% of the equity through two special purpose vehicles. A limited partnership enterprise set up mainly by SLC's new management team will hold the remaining 5%. The deal includes SLC's Beijing factory and production equipment. Shiseido said it believes independent operation under IDG will support SLC's sustainable growth and brand value.

To ensure a smooth handover, Shiseido will license the intellectual property rights IDG needs to run the business. For a specified period after the transfer, Shiseido will provide support on new product development, technical assistance for the stable supply of existing products, and continued supply of raw materials and selected products. The company says the collaboration is intended to maintain SLC's innovation capabilities, product quality and business continuity.

Shiseido says the divestment sheds a business that requires continued investment in product innovation and digital capabilities. The sale comes days after the company reported a 124.3% jump in core operating profit for the third quarter of 2026, to ¥67.5 billion (US$422.13 million). Shiseido attributed the recovery to restructuring, cost cuts and improved margins rather than strong product demand; like-for-like sales grew 0.7%. It raised its full-year core operating profit forecast from ¥59 billion (US$433 million) to ¥87 billion (US$546 million).